Five-year quality of life of endometrial cancer patients treated in the randomised Post Operative Radiation Therapy in Endometrial Cancer (PORTEC-2) trial and comparison with norm data

Presented at: Part of this research has been presented at the 29th Biennial European Society of Radiation Oncology (ESTRO) Conference, Barcelona, Spain, September 12–16, 2010.

Remi A. Nout
- Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands
- Corresponding author: Address: Department of Clinical Oncology, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands. Tel.: +31 (0)71 5261990; fax: +31 (0)71 5266760.
- For the PORTEC Study Group.
Hein Putter
- Department of Medical Statistics, Leiden University Medical Center, Leiden, The Netherlands
- For the PORTEC Study Group.
Ina M. Jürgenliemk-Schulz
- Department of Radiation Oncology, University Medical Center Utrecht, The Netherlands
- For the PORTEC Study Group.
Jan J. Jobsen
- Department of Radiotherapy, Medisch Spectrum Twente, Enschede, The Netherlands
- For the PORTEC Study Group.
Ludy C.H.W. Lutgens
- MAASTtricht Radiation Oncology Clinic, The Netherlands
- For the PORTEC Study Group.
Elzbieta M. van der Steen-Banasik
- Arnhem Radiotherapy Institute, Arnhem, The Netherlands
- For the PORTEC Study Group.
Jan Willem M. Mens
- Department of Radiation Oncology, Erasmus MC–Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
- For the PORTEC Study Group.
Annerie Slot
- Radiotherapy Institute Friesland, Leeuwarden, The Netherlands
- For the PORTEC Study Group.
Marika C. Stenfert Kroese
- Radiotherapy Institute Stedendriehoek en Omstreken, Deventer, The Netherlands
- For the PORTEC Study Group.
Hans W. Nijman
- Department of Gynecology, University Medical Center Groningen, The Netherlands
- For the PORTEC Study Group.
Lonneke V. van de Poll-Franse
- Comprehensive Cancer Centre South, Eindhoven and Center of Research on Psychology in Somatic Diseases (CoRPS), Tilburg University, The Netherlands
- For the PORTEC Study Group.
Carien L. Creutzberg
- Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands
- For the PORTEC Study Group.